Skip to main content

Phosphoramidite Market Growth Statistics, Prominent Players Strategies, and Growth Forecast to 2032


 

Global Phosphoramidite Market: Industry Overview

The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032. The market growth can be ascribed to the rising demand for oligonucleotides, growing synthetic biology market, increasing partnerships and collaborations, continuous investment for research and development activities by private and public firms, and growing prevalence of several diseases creating an urgent need for novel therapeutic treatments.

Phosphoramidite Market

 

Recent Developments in the Global Phosphoramidite Market

•    In August 2019, the company acquired 75% ordinary capital of the parent company of Toronto Research Chemicals Inc., i.e., Biomed Pharmaceutical Limited.
•    In July 2022, TriLink BioTechnologies expanded its RD leadership team's responsibility for leading the company’s scientific direction and research and development strategy.
•    In May 2022, TriLink BioTechnologies announced a cooperative agreement with the Department of Defense and included funding for TriLink’s expansion in San Diego, California, for nucleic acid production.
•    In November 2021, Biosynth Carbosynth acquired Kexing Biopharmaceutical Co., Ltd.’s raw material manufacturing unit located in Jinan, China, to expand its operations and deliver a wide range of products at a larger production volume and increased capacity. The facility extends to more than 30,000 square meters of area.
•    In November 2021, a leading investment firm, KKR, invested an undisclosed amount and acquired Biosynth Carbosynth from its founders, Armira and Dr. Urs Spitz. However, senior management will retain a significant ownership stake, and KKR will contribute as a strategic partner. KKR plans to encourage and accelerate the company's product portfolio expansion and geographic buildout and widen its capabilities.

Global Phosphoramidite Market Segmentation

Demand - Drivers and Limitations

Following are the demand drivers for the global phosphoramidite market:

•    Increasing Synthetic Nucleotide Applications in Therapeutics
•    Growth in Synthetic Biology

The market is expected to face some limitations due to the following challenges:

•    Challenges in Developing Long Nucleotide Sequences
•    Competition from Emerging DNA Synthesis Technologies


Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

•    Biosynth Carbosynth
•    Bioneer Corporation
•    Lumiprobe Corporation
•    QIAGEN N.V.
•    Danaher Corporation (IDT)
•    TriLink BioTechnologies
•    Creative Biolabs
•    PolyOrg, Inc.
•    Hongene Biotech Corporation
•    ChemGenes
•    BOC Sciences
•    Tokyo Chemical Industry Co., Ltd. (TCI)
•    LGC Science Group Holdings Limited
•    AAT Bioquest, Inc.
•    Thermo Fisher Scientific, Inc.
•    Merck KGaA

 

 

  Key Questions Answered in the Report

  • What are the major market drivers, challenges, and opportunities in the global phosphoramidite market?
  • What are the key development strategies being implemented by the major players to sustain in the competitive market?
  • Which is the dominant phosphoramidite by type developed by the leading and emerging players?
  • What is the impact of COVID-19 on the global phosphoramidite market?
  • How is each segment of the market expected to grow during the forecast period from 2022 to 2032? Following are the segments:
  • Type (DNA phosphoramidites, RNA phosphoramidites, labeled phosphoramidites, and other phosphoramidites)
  • End User (Pharmaceutical and biotechnology companies, diagnostic laboratories, and synthetic biology or research institutes)
  • Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
  • Which companies are anticipated to be highly disruptive in the future, and why?

USP of this report

The following can be seen as some of the USPs of this report:

• Extensive competitive benchmarking of key players offering a holistic view of the global phosphoramidite market landscape 
• Market ranking analysis based on product portfolio, recent developments, and region-level analysis

 

Who should buy this report?

Established companies involved in the development of phosphoramidite-related products such as oligonucleotides and new entrants who want to focus on the phosphoramidite market would be suitable buyers for this report.


BIS Related Studies

Global Oligonucleotide Synthesis Market

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...
Post a Comment
Read more

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...
Post a Comment
Read more